Literature DB >> 23179811

[Preservatives from the perspective of glaucoma surgery].

H Thieme1, K K van der Velden.   

Abstract

Trabeculectomy is still the gold standard in the surgical treatment of glaucoma patients. Development of a bleb is the primary goal of this procedure and the conjunctival status is therefore decisive. Only a good functioning bleb renders good intraocular pressure (IOP) control. Scar tissue formation leads to bleb failure which is quite common despite the use of antiproliferative agents, such as mitomycin C and 5 fluoruracil. Wound healing is important and is influenced and impaired by the chronic use of topical antiglaucoma drugs. Therefore, complete abstinence is recommended from 4-6 weeks prior to a planned trabeculectomy; however, it seems mandatory to completely abolish preservatives such as drops containing benzalkonium chloride to enhance trabeculectomy success rates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179811     DOI: 10.1007/s00347-012-2642-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  24 in total

1.  The influence of prior therapy on the success of trabeculectomy.

Authors:  M J Lavin; R P Wormald; C S Migdal; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1990-11

2.  Blindness and low vision in Germany 1993-2009.

Authors:  Christian Wolfram; Norbert Pfeiffer
Journal:  Ophthalmic Epidemiol       Date:  2012-02       Impact factor: 1.648

3.  Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue.

Authors:  Tadashi Ito; Hiroshi Ohguro; Kazuhisa Mamiya; Ikuyo Ohguro; Mitsuru Nakazawa
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

4.  Effects of topical antiglaucoma application on conjunctival impression cytology specimens.

Authors:  Samin Hong; Christopher Seungkyu Lee; Kyoung Yul Seo; Gong Je Seong; Young Jae Hong
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

5.  Conjunctival markers as predictable markers for preoperative glaucoma assessment.

Authors:  P-J Pisella
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

6.  Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.

Authors:  Giulia Renieri; Katrin Führer; Karl Scheithe; Katrin Lorenz; Norbert Pfeiffer; Hagen Thieme
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-26       Impact factor: 2.671

7.  Chronic topical eye preservative-free beta-blocker therapy effect on the ocular surface in glaucomatous patients.

Authors:  P Campagna; A Macri; M Rolando; G Calabria
Journal:  Acta Ophthalmol Scand Suppl       Date:  1997

8.  Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study.

Authors:  R Nuzzi; A Vercelli; C Finazzo; C Cracco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-03       Impact factor: 3.117

Review 9.  Does medical treatment influence the success of trabeculectomy?

Authors:  Allan Joseph Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11
View more
  2 in total

1.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-06       Impact factor: 4.638

Review 2.  Glaucoma therapy: preservative-free for all?

Authors:  John Thygesen
Journal:  Clin Ophthalmol       Date:  2018-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.